Sarepta Therapeutics, Inc.
Head Quarters
Suite 415 215 First Street USWebsite
http://www.sareptatherapeutics.comIndustry
BiotechnologyEmployees
197Exchange
NASDAQSarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious, and other diseases. It focuses on the development of its potentially disease-modifying DMD drug candidates. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 6 |
| Gross Margin (%) | 0.71% |
| Net Margin (%) | 4.00% |
| Returns | Stock |
| Sales | $21.00M |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | -$57.00M |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 531.13 |
| EPS | -$2.00 |